(5-fluoro-2-methylphenyl)hydrazine | 2339-53-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (5-fluoro-2-methylphenyl)hydrazine
• CAS: 2339-53-9
• 化学式: C₇H₉FN₂
• mdl: MFCD09813199
• 分子量: 140.16
• InChiKey: IFKJTZLQRLTAIX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (5-fluoro-2-methylphenyl)hydrazine 在 盐酸 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 乙醇 、 二氯甲烷 、 水 为溶剂， 反应 32.0h， 生成 (9-fluoro-6-methyl-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-[5-(trifluoromethyl)-1H-pyrazol-3-yl]methanone
  参考文献：
  名称：

  Identification, Structure–Activity Relationship, and Biological Characterization of 2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indoles as a Novel Class of CFTR Potentiators

  摘要：

  Cystic fibrosis (CF) is a life-threatening autosomal recessive disease, caused by mutations in the CF transmembrane conductance regulator (CFTR) chloride channel. CFTR modulators have been reported to address the basic defects associated with CF-causing mutations, partially restoring the CFTR function in terms of protein processing and/or channel gating. Small-molecule compounds, called potentiators, are known to ameliorate the gating defect. In this study, we describe the identification of the 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole core as a novel chemotype of potentiators. In-depth structure-activity relationship studies led to the discovery of enantiomerically pure 39 endowed with a good efficacy in rescuing the gating defect of F508del- and G551D-CFTR and a promising in vitro druglike profile. The in vivo characterization of gamma-carboline 39 showed considerable exposure levels and good oral bioavailability, with detectable distribution to the lungs after oral administration to rats. Overall, these findings may represent an encouraging starting point to further expand this chemical class, adding a new chemotype to the existing classes of CFTR potentiators.

  DOI：

  10.1021/acs.jmedchem.0c01050
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 、 tin(ll) chloride 作用下， 生成 (5-fluoro-2-methylphenyl)hydrazine
  参考文献：
  名称：

  Suschitzky, Journal of the Chemical Society, 1953, p. 3326

  摘要：

  DOI：

文献信息

• THIAZOLIDINONE COMPOUNDS AND USE THEREOF
  申请人：National Health Research Institutes

  公开号：US20170253569A1

  公开（公告）日：2017-09-07

  A pharmaceutical composition containing a compound of Formula (I) for treating an opioid receptor-associated condition. Also disclosed is a method for treating an opioid receptor-associated condition using such a compound. Further disclosed are two sets of thiazolidinone compounds of formula (I): (i) compounds each having an enantiomeric excess greater than 90% and (ii) compounds each being substituted with deuterium.

  一种含有化合物（I）的药物组合物，用于治疗与阿片受体相关的疾病。还公开了一种使用这种化合物治疗阿片受体相关疾病的方法。进一步公开了两组式（I）的噻唑烷酮化合物：（i）每种化合物的对映体过量大于90%；（ii）每种化合物被氘取代。
• [EN] TRICYCLIC PYRAZOL AMINE DERIVATIVES<br/>[FR] DÉRIVÉS TRICYCLIQUES DE PYRAZOLAMINE
  申请人：MERCK SERONO SA

  公开号：WO2011058149A1

  公开（公告）日：2011-05-19

  This invention relates to compounds of Formula (I*) as Pi3k inhibitors for treating autoimmune diseases, inflammatory disorders, multiple sclerosis and other diseases like cancers.

  这项发明涉及到 Formula (I*) 的化合物作为 Pi3k 抑制剂，用于治疗自身免疫疾病、炎症性疾病、多发性硬化等疾病，以及癌症等其他疾病。
• THERAPEUTIC AGENTS 414
  申请人：BENNETT Stuart Norman Lile

  公开号：US20100093757A1

  公开（公告）日：2010-04-15

  A compound of Formula (I): is useful in the treatment or prevention of a disease or medical condition mediated through glucokinase (GLK or GK), leading to a decreased glucose threshold for insulin secretion.

  化合物Formula (I)在通过葡萄糖激酶（GLK或GK）介导的疾病或医疗状况的治疗或预防中很有用，导致胰岛素分泌的葡萄糖阈值降低。
• Palladium-Catalyzed Cross-Coupling of Aryl Chlorides and Tosylates with Hydrazine
  作者：Rylan J. Lundgren、Mark Stradiotto

  DOI：10.1002/anie.201003764

  日期：2010.11.8

  Hydrazine is not a problem anymore: The title transformation is the first reaction to yield aryl hydrazines through the cross‐coupling of aryl chlorides and tosylates with hydrazine. An appropriately designed palladium catalyst allows this reaction to proceed rapidly under mild conditions, and with excellent chemoselectivity (see scheme; Ad=adamantyl, Ts=4‐toluenesulfonyl).

  肼不再是问题：标题转化是通过芳基氯化物和甲苯磺酸与甲苯磺酸酯的交叉偶联反应生成芳基肼的第一个反应。适当设计的钯催化剂可使该反应在温和条件下快速进行，并具有出色的化学选择性（参见方案； Ad =金刚烷基，Ts = 4-甲苯磺酰基）。
• Synthesis, Spectroscopic Analysis and Assessment of the Biological Activity of New Hydrazine and Hydrazide Derivatives of 3-Formylchromone
  作者：Krzysztof Słomiak、Andrzej Łazarenkow、Lilianna Chęcińska、Joachim Kusz、Justyn Ochocki、Jolanta Nawrot-Modranka

  DOI：10.3390/molecules23082067

  日期：——

  hydrazine and hydrazide derivatives of benzo-γ-pyrones with fluorine substituents remain an unexplored group of chemical compounds. This preliminary study reports the synthesis, structural assessment, initial microbiological screening and biological testing of the synthesized compounds on cell lines using the XTT-assay. A series of 10 novel hydrazine and hydrazide derivatives of 3-formylchromone were

  具有氟取代基的苯并-γ-吡喃酮的肼和酰肼衍生物仍然是一组未开发的化合物。这项初步研究报告了使用 XTT 测定对合成化合物在细胞系上的合成、结构评估、初步微生物筛选和生物测试。合成了一系列 10 种新型 3-甲酰色酮的肼和酰肼衍生物，并确定了它们的结构。结构评估包括元素分析、IR、1H-NMR、13C-NMR、MS 和晶体学研究。对代表不同微生物组的标准菌株进行了抗菌活性测试。发现测试的化合物可以抑制微生物生长。研究发现 0.01⁻1250 µmol/L 的浓度会影响细胞增殖，对两种细胞系具有抗增殖和刺激增殖作用：L929 细胞系（小鼠成纤维细胞系）和 EA.hy926 细胞系（人脐静脉、体细胞）细胞杂交）。